Mackenzie Financial Corp Surmodics Inc Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.39 - $42.1 $161,023 - $266,998	6,342 New	6,342 $266,000
Q3 2019 Nov 14, 2019	SELL	$38.66 - $47.41 $402,063 - $493,063	-10,400 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$38.23 - $47.43 $1.17 Million - $1.45 Million	-30,660 Reduced 74.67%	10,400 $449,000
Q1 2019 May 15, 2019	SELL	$41.26 - $58.35 $55,082 - $77,897	-1,335 Reduced 3.15%	41,060 $1.79 Million
Q4 2018 Feb 06, 2019	BUY	$44.93 - $73.38 $587,010 - $958,709	13,065 Added 44.54%	42,395 $2 Million
Q3 2018 Nov 15, 2018	BUY	$56.85 - $80.35 $1.67 Million - $2.36 Million	29,330 New	29,330 $2.19 Million

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.